Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	lactoperoxidase activity	PXDN LPO EPX	1.72e-07	4	71	3	GO:0140825
GeneOntologyMolecularFunction	heme binding	MPO PXDN CYP2F1 LPO CYP4F2 EPX	1.81e-05	154	71	6	GO:0020037
GeneOntologyMolecularFunction	tetrapyrrole binding	MPO PXDN CYP2F1 LPO CYP4F2 EPX	2.58e-05	164	71	6	GO:0046906
GeneOntologyMolecularFunction	peroxidase activity	MPO PXDN LPO EPX	8.43e-05	65	71	4	GO:0004601
GeneOntologyMolecularFunction	oxidoreductase activity, acting on peroxide as acceptor	MPO PXDN LPO EPX	9.50e-05	67	71	4	GO:0016684
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM5C KDM5D UTY	1.32e-04	28	71	3	GO:0141052
GeneOntologyMolecularFunction	histone demethylase activity	KDM5C KDM5D UTY	1.80e-04	31	71	3	GO:0032452
GeneOntologyMolecularFunction	histone H3K4me/H3K4me2/H3K4me3 demethylase activity	KDM5C KDM5D	1.85e-04	6	71	2	GO:0034647
GeneOntologyMolecularFunction	protein demethylase activity	KDM5C KDM5D UTY	1.98e-04	32	71	3	GO:0140457
GeneOntologyMolecularFunction	histone H3K4 demethylase activity	KDM5C KDM5D	3.44e-04	8	71	2	GO:0032453
GeneOntologyMolecularFunction	antioxidant activity	MPO PXDN LPO EPX	3.96e-04	97	71	4	GO:0016209
GeneOntologyMolecularFunction	demethylase activity	KDM5C KDM5D UTY	5.14e-04	44	71	3	GO:0032451
GeneOntologyMolecularFunction	aryl sulfotransferase activity	SULT1C2 SULT1C4	5.51e-04	10	71	2	GO:0004062
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CYP2F1 KDM5C CYP4F2 KDM5D UTY	6.37e-04	194	71	5	GO:0016705
GeneOntologyMolecularFunction	sulfotransferase activity	SULT1C2 SULT6B1 SULT1C4	9.90e-04	55	71	3	GO:0008146
GeneOntologyMolecularFunction	oxidoreductase activity	MPO PXDN CYP2F1 KDM5C LPO CYP4F2 KDM5D EPX UTY	1.52e-03	766	71	9	GO:0016491
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM5C KDM5D UTY	1.61e-03	65	71	3	GO:0016706
GeneOntologyMolecularFunction	transferase activity, transferring sulphur-containing groups	SULT1C2 SULT6B1 SULT1C4	2.33e-03	74	71	3	GO:0016782
GeneOntologyMolecularFunction	sialyltransferase activity	ST6GAL1 ST8SIA3	2.51e-03	21	71	2	GO:0008373
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2F1 CYP4F2	3.27e-03	24	71	2	GO:0008392
GeneOntologyBiologicalProcess	hydrogen peroxide catabolic process	MPO PXDN LPO EPX	4.62e-06	33	70	4	GO:0042744
GeneOntologyBiologicalProcess	response to toxic substance	MPO PXDN CYP2F1 KDM5C LPO GRIA1 EPX	5.56e-05	289	70	7	GO:0009636
GeneOntologyBiologicalProcess	hydrogen peroxide metabolic process	MPO PXDN LPO EPX	7.93e-05	67	70	4	GO:0042743
GeneOntologyBiologicalProcess	sulfation	SULT1C2 SULT6B1 SULT1C4	1.03e-04	27	70	3	GO:0051923
HumanPheno	Parietal cortical atrophy	MAGEL2 TMEM147 NDN	1.36e-05	8	33	3	HP:0012104
Domain	PEROXIDASE_1	MPO PXDN LPO EPX	2.86e-09	6	71	4	PS00435
Domain	Haem_peroxidase	MPO PXDN LPO EPX	3.96e-08	10	71	4	IPR010255
Domain	An_peroxidase	MPO PXDN LPO EPX	3.96e-08	10	71	4	PF03098
Domain	PEROXIDASE_3	MPO PXDN LPO EPX	3.96e-08	10	71	4	PS50292
Domain	Haem_peroxidase_animal	MPO PXDN LPO EPX	3.96e-08	10	71	4	IPR019791
Domain	-	MPO PXDN LPO EPX	3.96e-08	10	71	4	1.10.640.10
Domain	Lys_sp_deMease-like_dom	KDM5C KDM5D	8.51e-05	4	71	2	IPR013637
Domain	PLU-1	KDM5C KDM5D	8.51e-05	4	71	2	PF08429
Domain	REJ	PKD1L1 PKD1	8.51e-05	4	71	2	PS51111
Domain	REJ_dom	PKD1L1 PKD1	8.51e-05	4	71	2	IPR014010
Domain	JmjC	KDM5C KDM5D UTY	1.01e-04	24	71	3	PF02373
Domain	zf-C5HC2	KDM5C KDM5D	1.41e-04	5	71	2	PF02928
Domain	Znf_C5HC2	KDM5C KDM5D	1.41e-04	5	71	2	IPR004198
Domain	PKD/REJ-like	PKD1L1 PKD1	2.12e-04	6	71	2	IPR002859
Domain	REJ	PKD1L1 PKD1	2.12e-04	6	71	2	PF02010
Domain	JMJC	KDM5C KDM5D UTY	2.41e-04	32	71	3	PS51184
Domain	JmjC_dom	KDM5C KDM5D UTY	2.41e-04	32	71	3	IPR003347
Domain	JmjC	KDM5C KDM5D UTY	2.65e-04	33	71	3	SM00558
Domain	IRF-3	IRF5 IRF6	2.96e-04	7	71	2	PF10401
Domain	PKD	PKD1L1 PKD1	2.96e-04	7	71	2	PF00801
Domain	Interferon_reg_factor-3	IRF5 IRF6	2.96e-04	7	71	2	IPR019471
Domain	IRF-3	IRF5 IRF6	2.96e-04	7	71	2	SM01243
Domain	Sulfotransferase_dom	SULT1C2 SULT6B1 SULT1C4	3.44e-04	36	71	3	IPR000863
Domain	Sulfotransfer_1	SULT1C2 SULT6B1 SULT1C4	3.44e-04	36	71	3	PF00685
Domain	GPS	CELSR2 PKD1L1 PKD1	3.44e-04	36	71	3	PS50221
Domain	GPS	CELSR2 PKD1L1 PKD1	3.73e-04	37	71	3	IPR000203
Domain	K_chnl_volt-dep_Kv1	KCNA3 KCNA6	3.93e-04	8	71	2	IPR003972
Domain	IRF	IRF5 IRF6	5.04e-04	9	71	2	SM00348
Domain	Interferon_reg_fact_DNA-bd_dom	IRF5 IRF6	5.04e-04	9	71	2	IPR001346
Domain	IRF	IRF5 IRF6	5.04e-04	9	71	2	PF00605
Domain	PKD/Chitinase_dom	PKD1L1 PKD1	5.04e-04	9	71	2	IPR022409
Domain	IRF_1	IRF5 IRF6	5.04e-04	9	71	2	PS00601
Domain	PKD	PKD1L1 PKD1	5.04e-04	9	71	2	SM00089
Domain	Interferon_reg_fac_CS	IRF5 IRF6	5.04e-04	9	71	2	IPR019817
Domain	IRF_2	IRF5 IRF6	5.04e-04	9	71	2	PS51507
Domain	JmjN	KDM5C KDM5D	6.29e-04	10	71	2	SM00545
Domain	JMJN	KDM5C KDM5D	6.29e-04	10	71	2	PS51183
Domain	JmjN	KDM5C KDM5D	6.29e-04	10	71	2	PF02375
Domain	JmjN	KDM5C KDM5D	6.29e-04	10	71	2	IPR003349
Domain	PKD	PKD1L1 PKD1	7.66e-04	11	71	2	PS50093
Domain	PKD_dom	PKD1L1 PKD1	7.66e-04	11	71	2	IPR000601
Domain	PKD_channel	PKD1L1 PKD1	7.66e-04	11	71	2	PF08016
Domain	PKD1_2_channel	PKD1L1 PKD1	7.66e-04	11	71	2	IPR013122
Domain	-	PKD1L1 PKD1	7.66e-04	11	71	2	2.60.40.670
Domain	-	KDM5C KDM5D	1.45e-03	15	71	2	1.10.150.60
Domain	BRIGHT	KDM5C KDM5D	1.45e-03	15	71	2	SM00501
Domain	ARID_dom	KDM5C KDM5D	1.45e-03	15	71	2	IPR001606
Domain	ARID	KDM5C KDM5D	1.45e-03	15	71	2	PS51011
Domain	ARID	KDM5C KDM5D	1.45e-03	15	71	2	PF01388
Domain	Sialyl_trans	ST6GAL1 ST8SIA3	1.45e-03	15	71	2	IPR012163
Domain	SMAD_dom-like	IRF5 IRF6	1.65e-03	16	71	2	IPR017855
Domain	-	IRF5 IRF6	1.65e-03	16	71	2	2.60.200.10
Domain	LH2	PKD1L1 PKD1	2.10e-03	18	71	2	SM00308
Domain	Glyco_trans_29	ST6GAL1 ST8SIA3	2.59e-03	20	71	2	IPR001675
Domain	Glyco_transf_29	ST6GAL1 ST8SIA3	2.59e-03	20	71	2	PF00777
Domain	PLAT	PKD1L1 PKD1	2.86e-03	21	71	2	PS50095
Domain	-	PKD1L1 PKD1	2.86e-03	21	71	2	2.60.60.20
Domain	PLAT	PKD1L1 PKD1	2.86e-03	21	71	2	PF01477
Domain	PLAT/LH2_dom	PKD1L1 PKD1	2.86e-03	21	71	2	IPR001024
Domain	K_chnl_volt-dep_Kv	KCNA3 KCNA6	4.70e-03	27	71	2	IPR003968
Domain	Cys-rich_flank_reg_C	LRFN4 PXDN PKD1	4.88e-03	90	71	3	IPR000483
Domain	LRRCT	LRFN4 PXDN PKD1	4.88e-03	90	71	3	SM00082
Domain	EGF_LAM_2	CELSR2 LAMA3	5.79e-03	30	71	2	PS50027
Domain	EGF_LAM_1	CELSR2 LAMA3	5.79e-03	30	71	2	PS01248
Domain	Ig_I-set	LRFN4 PXDN MERTK VSIG10	5.93e-03	190	71	4	IPR013098
Domain	I-set	LRFN4 PXDN MERTK VSIG10	5.93e-03	190	71	4	PF07679
Pathway	WP_SULFATION_BIOTRANSFORMATION_REACTION	SULT1C2 SULT6B1 SULT1C4	3.48e-05	17	54	3	M39483
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1C2 SULT6B1 SULT1C4	1.02e-04	24	54	3	M16289
Pathway	REACTOME_HDMS_DEMETHYLATE_HISTONES	KDM5C KDM5D UTY	1.81e-04	29	54	3	MM14934
Pubmed	The potential for repositioning antithyroid agents as antiasthma drugs.	MPO LPO EPX	8.15e-09	3	71	3	27444178
Pubmed	Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model.	MPO PXDN EPX	8.15e-09	3	71	3	30565999
Pubmed	Thiocyanate modulates the catalytic activity of mammalian peroxidases.	MPO LPO EPX	8.15e-09	3	71	3	15894800
Pubmed	The evolutionary conservation of the mammalian peroxidase genes.	MPO LPO EPX	8.15e-09	3	71	3	12584448
Pubmed	The eosinophil peroxidase gene forms a cluster with the genes for myeloperoxidase and lactoperoxidase on human chromosome 17.	MPO LPO EPX	8.15e-09	3	71	3	10828600
Pubmed	X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.	KDM5C KDM5D UTY	3.26e-08	4	71	3	32732223
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	KDM5C KDM5D UTY	2.30e-06	13	71	3	14660691
Pubmed	Structural and chemical profiling of the human cytosolic sulfotransferases.	SULT1C2 SULT6B1 SULT1C4	2.30e-06	13	71	3	17425406
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	PLA2G4B KDM5C KDM5D UTY	3.15e-06	49	71	4	34368113
Pubmed	Uncovering a new role for peroxidase enzymes as drivers of angiogenesis.	MPO EPX	4.11e-06	2	71	2	26386352
Pubmed	Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.	MPO EPX	4.11e-06	2	71	2	28260049
Pubmed	Interferon Regulatory Factor-5 in Resident Macrophage Promotes Polycystic Kidney Disease.	PKD1 IRF5	4.11e-06	2	71	2	33490963
Pubmed	Human sulfotransferases SULT1C1 and SULT1C2: cDNA characterization, gene cloning, and chromosomal localization.	SULT1C2 SULT1C4	4.11e-06	2	71	2	10783263
Pubmed	Mouse H-Y encoding Smcy gene and its X chromosomal homolog Smcx.	KDM5C KDM5D	4.11e-06	2	71	2	10441747
Pubmed	Inefficient purifying selection: the mammalian Y chromosome in the rodent genus Mus.	KDM5C KDM5D	4.11e-06	2	71	2	16416087
Pubmed	Peroxidase enzymes inhibit osteoclast differentiation and bone resorption.	MPO EPX	4.11e-06	2	71	2	27836774
Pubmed	A genetic locus for paranoia.	MAGEL2 NDN	4.11e-06	2	71	2	29343559
Pubmed	UBE4B interacts with the ITCH E3 ubiquitin ligase to induce Ku70 and c-FLIPL polyubiquitination and enhanced neuroblastoma apoptosis.	ITCH UBE4B	4.11e-06	2	71	2	37957138
Pubmed	Molecular cloning, expression, and characterization of novel human SULT1C sulfotransferases that catalyze the sulfonation of N-hydroxy-2-acetylaminofluorene.	SULT1C2 SULT1C4	4.11e-06	2	71	2	9852044
Pubmed	Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.	KDM5C KDM5D	4.11e-06	2	71	2	32081420
Pubmed	Analysis of mutation rates in the SMCY/SMCX genes shows that mammalian evolution is male driven.	KDM5C KDM5D	4.11e-06	2	71	2	9060413
Pubmed	Increased Expression of Y-Encoded Demethylases During Differentiation of Human Male Neural Stem Cells.	KDM5D UTY	4.11e-06	2	71	2	33040644
Pubmed	Hereditary eosinophil peroxidase deficiency: immunochemical and spectroscopic studies and evidence for a compound heterozygosity of the defect.	MPO EPX	4.11e-06	2	71	2	7809065
Pubmed	The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region.	MAGEL2 NDN	4.11e-06	2	71	2	10556298
Pubmed	A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens.	KDM5C KDM5D	4.11e-06	2	71	2	7524912
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	KDM5C KDM5D UTY	6.51e-06	18	71	3	12023983
Pubmed	Expression and imprinting of MAGEL2 suggest a role in Prader-willi syndrome and the homologous murine imprinting phenotype.	MAGEL2 NDN	1.23e-05	3	71	2	10915770
Pubmed	Population genetic implications from sequence variation in four Y chromosome genes.	KDM5D UTY	1.23e-05	3	71	2	10861003
Pubmed	Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program.	EPX TRIB1	1.23e-05	3	71	2	30917956
Pubmed	Identification of a mouse male-specific transplantation antigen, H-Y.	KDM5C KDM5D	1.23e-05	3	71	2	7544442
Pubmed	A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily.	SULT1C2 SULT1C4	1.23e-05	3	71	2	15167709
Pubmed	Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.	ITCH HIPK2	1.23e-05	3	71	2	28455968
Pubmed	The Prader-Willi syndrome murine imprinting center is not involved in the spatio-temporal transcriptional regulation of the Necdin gene.	MAGEL2 NDN	1.23e-05	3	71	2	15634360
Pubmed	Novel JARID1C/SMCX mutations in patients with X-linked mental retardation.	KDM5C KDM5D	2.46e-05	4	71	2	16541399
Pubmed	Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity.	SULT1C2 SULT1C4	2.46e-05	4	71	2	24028175
Pubmed	Transposition of RhoA to the murine Y chromosome.	KDM5D UTY	2.46e-05	4	71	2	9598304
Pubmed	Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development.	MAGEL2 NDN	2.46e-05	4	71	2	18930956
Pubmed	The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases.	KDM5C KDM5D	2.46e-05	4	71	2	17320160
Pubmed	Activation of α7 nicotinic acetylcholine receptor protects against oxidant stress damage through reducing vascular peroxidase-1 in a JNK signaling-dependent manner in endothelial cells.	PXDN MAPK9	2.46e-05	4	71	2	24556843
Pubmed	Prader-Willi syndrome transcripts are expressed in phenotypically significant regions of the developing mouse brain.	MAGEL2 NDN	2.46e-05	4	71	2	12971993
Pubmed	Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.	HIPK2 MAPK9	2.46e-05	4	71	2	27321923
Pubmed	IRF6 and TAK1 coordinately promote the activation of HIPK2 to stimulate apoptosis during palate fusion.	HIPK2 IRF6	2.46e-05	4	71	2	31387937
Pubmed	A novel X gene with a widely transcribed Y-linked homologue escapes X-inactivation in mouse and human.	KDM5C KDM5D	2.46e-05	4	71	2	7951230
Pubmed	JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.	MAPK9 KIT	2.46e-05	4	71	2	21135226
Pubmed	Basal cancer cell survival involves JNK2 suppression of a novel JNK1/c-Jun/Bcl-3 apoptotic network.	ITCH MAPK9	4.09e-05	5	71	2	19806201
Pubmed	A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene.	MAGEL2 NDN	4.09e-05	5	71	2	20876615
Pubmed	The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.	KDM5D UTY	4.09e-05	5	71	2	16299505
Pubmed	Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow.	KCNA3 KCNA6	4.09e-05	5	71	2	21233214
Pubmed	Necdin-related MAGE proteins differentially interact with the E2F1 transcription factor and the p75 neurotrophin receptor.	MAGEL2 NDN	4.09e-05	5	71	2	14593116
Pubmed	The Gastric Mucosa from Patients Infected with CagA+ or VacA+ Helicobacter pylori Has a Lower Level of Dual Oxidase-2 Expression than Uninfected or Infected with CagA-/VacA- H. pylori.	MPO LPO	4.09e-05	5	71	2	27048452
Pubmed	c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease.	PKD1 MAPK9	4.09e-05	5	71	2	34962918
Pubmed	Retrotransposed genes such as Frat3 in the mouse Chromosome 7C Prader-Willi syndrome region acquire the imprinted status of their insertion site.	MAGEL2 NDN	4.09e-05	5	71	2	11845283
Pubmed	Sexually dimorphic gene expression in the developing mouse gonad.	KDM5D KIT UTY	5.09e-05	35	71	3	12617826
Pubmed	Genetic differences between five European populations.	IRF5 LCT	6.13e-05	6	71	2	20616560
Pubmed	Deletion of the MBII-85 snoRNA gene cluster in mice results in postnatal growth retardation.	MAGEL2 NDN	6.13e-05	6	71	2	18166085
Pubmed	Physical mapping of potassium channel gene clusters on mouse chromosomes three and six.	KCNA3 KCNA6	6.13e-05	6	71	2	9286706
Pubmed	Recommendations for the investigation of animal models of Prader-Willi syndrome.	MAGEL2 NDN	6.13e-05	6	71	2	23609791
Pubmed	Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1, causes megencephaly.	KCNA3 KCNA6	6.13e-05	6	71	2	14686897
Pubmed	Pyroptosis triggers pore-induced intracellular traps (PITs) that capture bacteria and lead to their clearance by efferocytosis.	MPO MERTK	8.57e-05	7	71	2	27573815
Pubmed	The mouse Y chromosome interval necessary for spermatogonial proliferation is gene dense with syntenic homology to the human AZFa region.	KDM5D UTY	8.57e-05	7	71	2	9736773
Pubmed	Imprinting analysis of the mouse chromosome 7C region in DNMT1-null embryos.	MAGEL2 NDN	8.57e-05	7	71	2	25300248
Pubmed	Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor.	LAMA3 ITGA7	8.57e-05	7	71	2	9004048
Pubmed	Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.	PKD1L1 MERTK	8.57e-05	7	71	2	22841784
Pubmed	Novel effects of chromosome Y on cardiac regulation, chromatin remodeling, and neonatal programming in male mice.	KDM5D UTY	8.57e-05	7	71	2	24105479
Pubmed	Reduced polyalanine-expanded Arx mutant protein in developing mouse subpallium alters Lmo1 transcriptional regulation.	KDM5C GRIA1	1.14e-04	8	71	2	24122442
Pubmed	Smchd1 regulates a subset of autosomal genes subject to monoallelic expression in addition to being critical for X inactivation.	MAGEL2 NDN	1.14e-04	8	71	2	23819640
Pubmed	KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium.	KCNA3 KCNA6	1.14e-04	8	71	2	21859894
Pubmed	The Prader-Willi syndrome proteins MAGEL2 and necdin regulate leptin receptor cell surface abundance through ubiquitination pathways.	MAGEL2 NDN	1.47e-04	9	71	2	28973533
Pubmed	Large scale replication analysis of loci associated with lipid concentrations in a Japanese population.	CELSR2 TRIB1	1.47e-04	9	71	2	19487539
Pubmed	Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7.	KCNA3 KCNA6	1.47e-04	9	71	2	9488722
Pubmed	Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth.	MAGEL2 NDN	1.83e-04	10	71	2	15649943
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	PKD1L1 PKD1	1.83e-04	10	71	2	16805797
Pubmed	Developmental expression of voltage-sensitive K+ channels in mouse skeletal muscle and C2C12 cells.	KCNA3 KCNA6	1.83e-04	10	71	2	1383027
Pubmed	The imprinted gene Magel2 regulates normal circadian output.	MAGEL2 NDN	1.83e-04	10	71	2	17893678
Pubmed	Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.	SULT1C2 SULT1C4	1.83e-04	10	71	2	11535246
Pubmed	Genetic Analysis Reveals a Hierarchy of Interactions between Polycystin-Encoding Genes and Genes Controlling Cilia Function during Left-Right Determination.	PKD1L1 PKD1	2.23e-04	11	71	2	27272319
Pubmed	Sulfotransferases in the bioactivation of xenobiotics.	SULT1C2 SULT1C4	2.23e-04	11	71	2	11154739
Pubmed	Fine-mapping in African Americans of 8 recently discovered genetic loci for plasma lipids: the Jackson Heart Study.	CELSR2 TRIB1	2.23e-04	11	71	2	20570916
Pubmed	Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.	MAGEL2 NDN	2.23e-04	11	71	2	24911587
Pubmed	Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.	SULT1C2 SULT1C4	2.23e-04	11	71	2	9034160
Pubmed	Sulfotransferases: genetics and role in toxicology.	SULT1C2 SULT1C4	2.23e-04	11	71	2	10720750
Pubmed	Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide.	SETX HIPK2	2.68e-04	12	71	2	24244371
Pubmed	Congenital hydrocephalus in genetically engineered mice.	CELSR2 POMK	2.68e-04	12	71	2	21746835
Pubmed	The role of Dby mRNA in early development of male mouse zygotes.	KDM5D UTY	2.68e-04	12	71	2	20543856
Pubmed	HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification.	MAGEL2 NDN	3.16e-04	13	71	2	18483557
Pubmed	Dynamic patterns of histone H3 lysine 4 methyltransferases and demethylases during mouse preimplantation development.	KDM5C KDM5D	3.16e-04	13	71	2	24619213
Pubmed	Quantitative analysis of expression of mouse sialyltransferase genes by competitive PCR.	ST6GAL1 ST8SIA3	4.24e-04	15	71	2	10381338
Pubmed	Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors.	MPO LPO	4.24e-04	15	71	2	19505917
Pubmed	Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin.	LAMA3 MERTK	4.24e-04	15	71	2	34721382
Pubmed	Constitutively active mutation of ACVR1 in oral epithelium causes submucous cleft palate in mice.	IRF6 MAPK9	4.24e-04	15	71	2	26116174
Pubmed	Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.	KDM5C KDM5D	4.24e-04	15	71	2	14762062
Pubmed	Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome".	SETX DNAH1	4.84e-04	16	71	2	29878059
Pubmed	Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development.	PTCH2 LAMA3	4.84e-04	16	71	2	12533516
Pubmed	ADAMTS18 Deficiency Affects Neuronal Morphogenesis and Reduces the Levels of Depression-like Behaviors in Mice.	LAMA3 ADAMTS18	4.84e-04	16	71	2	30579834
Pubmed	Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.	CELSR2 TRIB1	4.84e-04	16	71	2	24886709
Pubmed	Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.	KCNA3 KCNA6	4.84e-04	16	71	2	28283561
Pubmed	Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase.	PXDN MAPK9	5.48e-04	17	71	2	12023963
Pubmed	Activin promotes differentiation of cultured mouse trophoblast stem cells towards a labyrinth cell fate.	KDM5C CFC1B	5.48e-04	17	71	2	19716815
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	SULT1C2 SULT1C4	6.16e-04	18	71	2	20056724
Pubmed	Generation of a Single-Cell RNAseq Atlas of Murine Salivary Gland Development.	LPO KIT	6.16e-04	18	71	2	33305192
Cytoband	17q23.1	MPO HEATR6 LPO EPX	9.97e-09	16	72	4	17q23.1
Cytoband	Yq11	KDM5D UTY	1.58e-04	12	72	2	Yq11
Cytoband	18q21.31	ATP8B1 ST8SIA3	2.87e-04	16	72	2	18q21.31
Cytoband	2q12.3	SULT1C2 SULT1C4	3.25e-04	17	72	2	2q12.3
Cytoband	Ensembl 112 genes in cytogenetic band chr17q22	MPO LPO EPX	3.69e-04	88	72	3	chr17q22
Cytoband	Ensembl 112 genes in cytogenetic band chr18q21	ZBTB7C ATP8B1 ST8SIA3	4.17e-03	205	72	3	chr18q21
GeneFamily	Sulfotransferases, cytosolic	SULT1C2 SULT6B1 SULT1C4	6.26e-06	14	48	3	762
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5C KDM5D UTY	3.42e-05	24	48	3	485
GeneFamily	AT-rich interaction domain containing	KDM5C KDM5D	7.09e-04	15	48	2	418
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRFN4 PXDN MERTK VSIG10	8.69e-04	161	48	4	593
GeneFamily	Sialyltransferases	ST6GAL1 ST8SIA3	1.27e-03	20	48	2	438
GeneFamily	MAGE family	MAGEL2 NDN	5.05e-03	40	48	2	1136
GeneFamily	Potassium voltage-gated channels	KCNA3 KCNA6	5.05e-03	40	48	2	274
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	MERTK KIT	5.05e-03	40	48	2	321
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	KDM5D UTY	8.10e-03	51	48	2	870
GeneFamily	Immunoglobulin like domain containing	MERTK VSIG10 KIT	1.46e-02	193	48	3	594
Coexpression	GSE27786_NKCELL_VS_ERYTHROBLAST_UP	UBR1 SETX SIPA1L3 PKD1 CRYBG1 KIT	1.74e-05	200	71	6	M4853
Coexpression	GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP	MAGEL2 CYP2F1 CCNA1 IRF6 NDN ST8SIA3	1.74e-05	200	71	6	M8203
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000	SAMD9L TMEM45B CYP2F1 SIPA1L3 LAMA3 SLC34A2 CRYBG1 IRF6 ATP8B1 EPS8L1 VSIG10	2.35e-05	736	69	11	gudmap_developingLowerUrinaryTract_adult_ureter_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_500	TMEM45B LAMA3 CRYBG1 IRF6 ATP8B1	2.94e-05	110	69	5	gudmap_developingLowerUrinaryTract_adult_ureter_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_1000	SAMD9L TMEM45B LAMA3 CRYBG1 IRF6 ATP8B1 EPS8L1	3.45e-05	280	69	7	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	MAGEL2 TMEM45B HIPK2 LAMA3 ADAMTS18 CRYBG1 IRF6 ATP8B1 EPS8L1 VSIG10 KIT	4.00e-05	780	69	11	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_1000	TMEM45B LAMA3 CRYBG1 IRF6 ATP8B1 EPS8L1	6.05e-05	209	69	6	gudmap_developingLowerUrinaryTract_adult_ureter_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000	SAMD9L TMEM45B LAMA3 CRYBG1 IRF6 ATP8B1	7.64e-05	218	69	6	gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	SHROOM3 MAGEL2 CELSR2 TMEM147 ST8SIA3 TRIB1	1.18e-04	236	69	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_500	SAMD9L TMEM45B ATP8B1 EPS8L1	1.48e-04	82	69	4	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_200	SAMD9L TMEM45B CRYBG1 IRF6 ATP8B1	1.59e-04	157	69	5	gudmap_developingLowerUrinaryTract_e15.5_urothelium_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_100	TMEM45B CRYBG1 IRF6 ATP8B1	1.62e-04	84	69	4	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_100
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_200	SAMD9L TMEM45B CRYBG1 IRF6 ATP8B1	1.74e-04	160	69	5	gudmap_developingKidney_e15.5_Medullary collecting duct_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500	MPO KCNA6 CELSR2 TMEM45B HIPK2 GRIA1 ADGRA1 ST8SIA3	1.80e-04	488	69	8	Facebase_RNAseq_e10.5_Medial Nasal Eminence_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_200	SAMD9L TMEM45B ATP8B1	1.99e-04	35	69	3	gudmap_developingLowerUrinaryTract_e15.5_Urothelium_200_k3
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#5_top-relative-expression-ranked_500	TMEM45B CRYBG1 IRF6 ATP8B1	2.30e-04	92	69	4	gudmap_developingKidney_e15.5_cortic collect duct_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000	HIPK2 LAMA3 ADAMTS18 CRYBG1 IRF6 ATP8B1 EPS8L1 KDM5D VSIG10 UTY	2.48e-04	800	69	10	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_500	SAMD9L TMEM45B CRYBG1 ATP8B1	2.71e-04	96	69	4	gudmap_developingLowerUrinaryTract_P1_ureter_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_500	MAGEL2 TMEM45B CRYBG1 IRF6 ATP8B1 VSIG10 KIT	2.75e-04	391	69	7	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500
CoexpressionAtlas	DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_500	SAMD9L TMEM45B HIPK2 CRYBG1 IRF6 ATP8B1 EPS8L1	2.88e-04	394	69	7	gudmap_developingKidney_e15.5_Medullary collecting duct_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500	SAMD9L TMEM45B LAMA3 CRYBG1 IRF6 ATP8B1 EPS8L1	2.88e-04	394	69	7	gudmap_developingLowerUrinaryTract_e15.5_urothelium_500
CoexpressionAtlas	ratio_EmbryoidBody-fibro_vs_EmbryoidBody-derived-from_CD34-iPSC_top-relative-expression-ranked_100	MPO STON1 KDM5D UTY	2.93e-04	98	69	4	PCBC_ratio_EB-fibro_vs_EB-cbCD34_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	MPO UIMC1 SETX KCNA6 CELSR2 TMEM45B HIPK2 GRIA1 ADGRA1 ST8SIA3 KIT	2.97e-04	979	69	11	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	PXDN ST6GAL1 KDM5D UTY	3.68e-04	104	69	4	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#3_top-relative-expression-ranked_200	TMEM45B CRYBG1 ATP8B1	4.51e-04	46	69	3	gudmap_developingLowerUrinaryTract_adult_ureter_200_k3
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SHROOM3 CELSR2 LAMA3 SLC34A2 ST6GAL1 VSIG10	6.90e-07	192	72	6	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	PRSS57 LAMA3 NDN SULT1C4 KIT	7.82e-06	168	72	5	90b33962adb77d8326dee403712118398b4d1315
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	PRSS57 LAMA3 NDN SULT1C4 KIT	8.28e-06	170	72	5	85c476e0bc496445e868a88849960598d97bdea2
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MPO PRSS57 ZBTB7C GRIA1 IRF5	8.76e-06	172	72	5	b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63
ToppCell	Ciliated_cells-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	CCNA1 ADGRA1 EPS8L1 HYDIN DNAH1	1.09e-05	180	72	5	bdea5ec6b60fc8c7cce4d71db5da74ac8675e211
ToppCell	COPD-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	PTCH2 HIPK2 ST6GAL1 MERTK TRIB1	1.15e-05	182	72	5	19db653fe04c5e2957eea1f4893b1c1fca4ddcbd
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6 SEC14L2	1.18e-05	183	72	5	06ac66726ec53db810ebb90ec69cfdb903da53f6
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CATIP PTCH2 ADAMTS18 GRIA1 ADGRA1	1.21e-05	184	72	5	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CATIP PTCH2 ADAMTS18 GRIA1 ADGRA1	1.21e-05	184	72	5	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 PTCH2 ADAMTS18 GRIA1 ADGRA1	1.21e-05	184	72	5	f6148e9591e8845cc62668e49fd52755257cdc7e
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 LAMA3 NDN SULT1C4 KIT	1.25e-05	185	72	5	2c07991e0907ded67e21ab2e66be21695842ed01
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	UIMC1 SAMD9L PTCH2 ITGA7 GARRE1	1.28e-05	186	72	5	76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PRSS57 NDN EPX SULT1C4 KIT	1.28e-05	186	72	5	943c604a7cd873faf510096d094100512ba2d6bc
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PRSS57 NDN EPX SULT1C4 KIT	1.28e-05	186	72	5	e69a986b8618effd61875fda528a2e44aab11868
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 PLA2G4B SIPA1L3 LAMA3 SLC34A2	1.31e-05	187	72	5	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 TMEM45B SIPA1L3 CRYBG1 ST6GAL1	1.45e-05	191	72	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CELSR2 TMEM45B CRYBG1 ST6GAL1 ATP8B1	1.49e-05	192	72	5	9e031bf93eb8757fdd0cc22f01b44e48f85532d5
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHROOM3 CELSR2 LAMA3 IRF6 TRIB1	1.69e-05	197	72	5	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SHROOM3 LAMA3 SLC34A2 IRF6 TRIB1	1.73e-05	198	72	5	1851b7f4198b42c21c934e2fbda39dbd65e2625c
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SHROOM3 LAMA3 SLC34A2 IRF6 TRIB1	1.73e-05	198	72	5	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	(06)_OLFM4+\|World / shred by cell type by condition	PXDN HIPK2 CCNA1 SLC34A2 KIT	1.77e-05	199	72	5	c773b9180dbfec9c19d4098dd43332e6f6050372
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	PLA2G4B LAMA3 SLC34A2 IRF6 EPS8L1	1.81e-05	200	72	5	eac33be484dc443794e66e473f03e98406c2983e
ToppCell	distal-2-Epithelial\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SHROOM3 TMEM45B SLC34A2 IRF6 HYDIN	1.81e-05	200	72	5	2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRSS57 PXDN NDN KIT	7.21e-05	137	72	4	6d90da42dcc06aa895f920218055068f3c76d57d
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT\|GI_small-bowel / Manually curated celltypes from each tissue	TMEM45B PLA2G4B PTCH2 IRF5	9.47e-05	147	72	4	4ba9a86ab7033688a9a2a2dc84c001a49af835b4
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SAMD9L LAMA3 SLC34A2 SEC14L2	1.16e-04	155	72	4	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	BAL-Mild-cDC_0\|Mild / Compartment, Disease Groups and Clusters	PRSS57 CELSR2 PTCH2 MERTK	1.41e-04	163	72	4	7047d3ba847930f42a6d5f71e18d49f3071c6409
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	MPO PRSS57 MERTK LCT	1.44e-04	164	72	4	d7053de88ef8e42cac6726a40e72f212659ee034
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PRSS57 SULT1C2 SIPA1L3	1.48e-04	165	72	4	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PRSS57 SULT1C2 SIPA1L3	1.48e-04	165	72	4	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	remission-HSPC\|World / disease stage, cell group and cell class	PRSS57 NDN VSIG10 KIT	1.51e-04	166	72	4	d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3
ToppCell	NS-control-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SULT1C2 ADGRA1 SULT1C4 KIT	1.51e-04	166	72	4	6d9fb239f69ba519844f593c00d515e1aac4ff50
ToppCell	wk_20-22-Hematologic-Myeloid-Mast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	SAMD9L PRSS57 EPX KIT	1.51e-04	166	72	4	004ab6a1425d812c7ce572205875fd702d4a9659
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SHROOM3 CYP2F1 ADAMTS18 IRF6	1.55e-04	167	72	4	29d271643f3a1718b53db77b7d093ec94225a824
ToppCell	wk_15-18-Hematologic-Myeloid-CMP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MPO PRSS57 IRF5 KIT	1.58e-04	168	72	4	9fc9c93ab7513bf4dfefc866b97c703208a238c9
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	FCSK NRDE2 LPO DNAH1	1.62e-04	169	72	4	dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	MPO PRSS57 ZBTB7C GRIA1	1.66e-04	170	72	4	aabe993c9f337b1caaeb0e64626a3920579c41b7
ToppCell	healthy_donor-Myeloid-Monocytic-Developing_Neutrophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	MPO PRSS57 PXDN TRIB1	1.66e-04	170	72	4	cfd7f29805b7c51666b0eaf269c36c96b8765a1a
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCSK CATIP CELSR2 ITGA7	1.69e-04	171	72	4	b54d9d6b03c9c6f28a71cf2ed2bfa9a335bba949
ToppCell	facs-Heart-RA-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCSK CATIP CELSR2 ITGA7	1.69e-04	171	72	4	9d825a2e799421af4f2cf4f4dc8e239b5d00476d
ToppCell	remission-HSPC\|remission / disease stage, cell group and cell class	PRSS57 NDN VSIG10 KIT	1.69e-04	171	72	4	41b424e58470a2fc25632aea50a37c7c5ea17645
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PRSS57 LPO ITGA7	1.69e-04	171	72	4	dca4aa921896ec935fb7acdf25a62d8eba679602
ToppCell	wk_15-18-Hematologic-Myeloid-GMP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MPO PRSS57 CRYBG1 EPX	1.69e-04	171	72	4	4b8b67c289898ae114a07a2147b5a6f8ec9dd308
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PRSS57 LPO ITGA7	1.69e-04	171	72	4	add2f7d34889ec654b8c71b4b1f084736111dc88
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MPO PRSS57 CYP4F2 KIT	1.73e-04	172	72	4	f18d9f061df3da96e389616abd5edfc269d3adeb
ToppCell	3'_v3-blood-Mast\|blood / Manually curated celltypes from each tissue	PRSS57 CCNA1 EPX KIT	1.73e-04	172	72	4	e7a46bbeff749ca59b9f1357409ce1ad59dd22dd
ToppCell	TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MPO CATIP CYP2F1 LPO	1.73e-04	172	72	4	6b8a8d3b97c10b9d092307eed3cacbd2745df185
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS57 CCNA1 EPX KIT	1.73e-04	172	72	4	2ab720a4c96073339a1f8b95ec7699682df98acf
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid\|bone_marrow / Manually curated celltypes from each tissue	MPO PRSS57 CYP4F2 SULT1C4	1.77e-04	173	72	4	5645a3b1e805c71d5d65fc8e4edc4e13208063fc
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 CELSR2 LAMA3 SLC34A2	1.77e-04	173	72	4	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 ZBTB7C VSIG10 DNAH1	1.81e-04	174	72	4	76310c0af1d7df6a4de3816838b2ac2892f68746
ToppCell	10x5'-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	PRSS57 STON1 CCNA1 KIT	1.81e-04	174	72	4	a5838821bba2be790d32331ff529d466e9974268
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CELSR2 SULT1C2 EPS8L1 URGCP	1.81e-04	174	72	4	2a96a4fd7d9ef05213b26103c689cf3a26968713
ToppCell	10x5'-blood-Mast\|blood / Manually curated celltypes from each tissue	PRSS57 STON1 CCNA1 KIT	1.81e-04	174	72	4	3a8a253213b207e3ff56f94a74996b8d9ad47aa1
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	PRSS57 NDN LCT KIT	1.81e-04	174	72	4	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 TMEM45B SLC34A2 ADGRA1	1.89e-04	176	72	4	533d544852038c0612aacf87f4b1c88ff7aace82
ToppCell	COVID-19-kidney-CD-IC-A\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SHROOM3 SULT1C2 ADAMTS18 KIT	1.89e-04	176	72	4	45028197364c64e93e3ffe86aff773d47a477d49
ToppCell	severe_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	PRSS57 NDN LCT KIT	1.93e-04	177	72	4	289f6aed6f054b04b01659434d8c8b467d1bf5dd
ToppCell	3'_v3-Lung-Hematopoietic_progenitors\|Lung / Manually curated celltypes from each tissue	MPO PRSS57 NDN SULT1C4	1.98e-04	178	72	4	c7895ba2e2e93b26da91faa2a3bf9d070dd4c3bd
ToppCell	3'_v3-Lung-Hematopoietic_progenitors-HSC-MPP\|Lung / Manually curated celltypes from each tissue	MPO PRSS57 NDN SULT1C4	2.02e-04	179	72	4	2c03b82ec9b4dee2501752b8d83e7028f0aaed77
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 CELSR2 LAMA3 SLC34A2	2.02e-04	179	72	4	cb38b54261a7af5ee3347e64c8aa880a77ed0763
ToppCell	Somatosensory_Cortex_(S1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ZBTB7C LAMA3 KDM5D UTY	2.02e-04	179	72	4	82348bf56a4525b2f485696cab5b2ea6e96c2f91
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MPO HIPK2 KDM5D KIT	2.06e-04	180	72	4	8e96f8646c002768b272359af485dc0ab57e0ccd
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 PLA2G4B LAMA3 SLC34A2	2.11e-04	181	72	4	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZBTB7C LAMA3 EPS8L1 ITGA7	2.11e-04	181	72	4	59527ad218e49386b04cabb97d53d2ed55a35961
ToppCell	COPD-Myeloid-DC_Mature\|World / Disease state, Lineage and Cell class	SIPA1L3 CRYBG1 MERTK KIT	2.11e-04	181	72	4	675603a401d92cf9fdcd44e211ec899fa86a0d49
ToppCell	Control-Epithelial_alveolar-AT_1-AT1-AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.15e-04	182	72	4	a95956ce4adccb34cc0c47ebfa1878ce4617904e
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CATIP CCNA1 TEX52 HYDIN	2.15e-04	182	72	4	000eca5baa6eb2335a1e6d76a13fff5382b0e150
ToppCell	hematopoetic_progenitors-CD34+_MEP_2\|World / Lineage and Cell class	PRSS57 CCNA1 EPX KIT	2.15e-04	182	72	4	a7e7aa10f14111a6c7ba22e0f1668dcaa124714d
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	SHROOM3 ADAMTS18 ST6GAL1 KIT	2.20e-04	183	72	4	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 PLA2G4B LAMA3 SLC34A2	2.24e-04	184	72	4	42ce855b4f8475a8298192feec785bdc69bc5bb0
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PRSS57 CCNA1 EPX KIT	2.24e-04	184	72	4	ce31684772e47a294155f368e50b49753f7c8e87
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.29e-04	185	72	4	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.29e-04	185	72	4	68f428e169cfb77de970bdfdeea9b9f16f68d2ba
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 SEC14L2	2.29e-04	185	72	4	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	LPS_only-Epithelial_alveolar-AT_1-AT1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.29e-04	185	72	4	0c247a3f394c42e2a6f67fee3d9cf33096fecd13
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.34e-04	186	72	4	e0a2ea4b46af742bc7c9b2072bb85e27d5c92712
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SULT1C2 LAMA3 ADAMTS18 SLC34A2	2.34e-04	186	72	4	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 SIPA1L3 SULT1C4 HYDIN	2.34e-04	186	72	4	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	Control-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	PTCH2 HIPK2 ST6GAL1 TRIB1	2.34e-04	186	72	4	a08a50bff4e629588faa22440d57334b1df0e8df
ToppCell	droplet-Fat-SCAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 CELSR2 CYP2F1 PKD1	2.38e-04	187	72	4	5fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCell	droplet-Fat-SCAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 CELSR2 CYP2F1 PKD1	2.38e-04	187	72	4	766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCell	PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SULT1C2 LAMA3 SLC34A2 ST6GAL1	2.38e-04	187	72	4	db2974e2e87ac9f1c2407a371d5ed89af09fc9b7
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 LAMA3 SLC34A2 IRF6	2.38e-04	187	72	4	ff26a533d310126521efe1d05cf8b9d32e524550
ToppCell	droplet-Fat-SCAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRFN4 CELSR2 CYP2F1 PKD1	2.38e-04	187	72	4	f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CRYBG1 ST6GAL1 ATP8B1 KIT	2.38e-04	187	72	4	2d17408b3b5f09d135084fd7ccce98e6b5ca632b
ToppCell	normal-na-Hematopoietic-progenitor_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 NDN SULT1C4 KIT	2.43e-04	188	72	4	013162466a3334b6967c0cb670c8577d809b1396
ToppCell	normal-na-Hematopoietic-progenitor_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	PRSS57 NDN SULT1C4 KIT	2.43e-04	188	72	4	be25371e6459504b5f0c9ece3a0fe8f80c7824ca
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM45B CRYBG1 ST6GAL1 ATP8B1	2.48e-04	189	72	4	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	PRSS57 NDN EPX KIT	2.48e-04	189	72	4	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM45B CRYBG1 ST6GAL1 ATP8B1	2.48e-04	189	72	4	bfc76a72b600d641c8fe58346e5d8986c34f3981
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	HIPK2 ST6GAL1 ATP8B1 GARRE1	2.48e-04	189	72	4	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	HIPK2 ST6GAL1 ATP8B1 GARRE1	2.48e-04	189	72	4	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 CRYBG1 ST6GAL1 KIT	2.48e-04	189	72	4	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	facs-BAT-Fat-24m-Epithelial-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM45B CYP2F1 IRF6 ATP8B1	2.48e-04	189	72	4	8e89365949b19e34b7dd4125b59db1c5ffb8340b
ToppCell	Healthy-HSPC\|Healthy / disease group, cell group and cell class	PRSS57 NDN SULT1C4 KIT	2.48e-04	189	72	4	214b225effc40ca1b83dd8052f2a7b80b65d4938
ToppCell	PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MPO PRSS57 CRYBG1 IRF5	2.53e-04	190	72	4	8e254fc77dd1d2d2a4ce0700af3c37829ca089bf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 CRYBG1 ST6GAL1 KIT	2.53e-04	190	72	4	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TMEM45B CRYBG1 ST6GAL1 ATP8B1	2.53e-04	190	72	4	11d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCell	IPF-Epithelial-Goblet\|IPF / Disease state, Lineage and Cell class	SHROOM3 CYP2F1 SLC34A2 EPS8L1	2.53e-04	190	72	4	e41dd5a997ad9952810ffecb57737c03ea1d88b3
Computational	Neighborhood of RAB3A	KCNA3 HIPK2 LCT KIT SEC14L2	3.27e-05	89	45	5	MORF_RAB3A
Drug	4-nitroestradiol	MPO LPO EPX	1.11e-07	4	70	3	CID000233494
Drug	Pummerer's ketone	MPO LPO EPX	2.77e-07	5	70	3	CID000099055
Drug	AC1MOE91	MPO LPO EPX	2.77e-07	5	70	3	CID003342294
Drug	isotrityrosine	MPO LPO EPX	2.77e-07	5	70	3	CID000196044
Drug	AC1Q6QQG	MPO LPO EPX	2.77e-07	5	70	3	CID000124376
Drug	2-chloro-1,4-dimethoxybenzene	MPO LPO EPX	2.77e-07	5	70	3	CID000246724
Drug	4-biphenylboronic acid	MPO LPO EPX	2.77e-07	5	70	3	CID000151253
Drug	t383	MPO LPO EPX	2.77e-07	5	70	3	CID000074847
Drug	selenocystein	MPO KCNA3 CYP2F1 RBMX2 LPO EPX MAPK9	2.87e-07	143	70	7	CID006326972
Drug	syringaldazine	MPO LPO EPX LCT	3.07e-07	19	70	4	CID005379425
Drug	5-hydroxyconiferyl alcohol	MPO LPO EPX	5.53e-07	6	70	3	CID005282095
Drug	PPHP	MPO LPO EPX	5.53e-07	6	70	3	CID006438577
Drug	4-methoxymandelic acid	MPO LPO EPX	5.53e-07	6	70	3	CID000112056
Drug	pulcherosine	MPO LPO EPX	5.53e-07	6	70	3	CID000124402
Drug	indamine	MPO LPO EPX	5.53e-07	6	70	3	CID000010841
Drug	3',4'-dehydrovinblastine	MPO LPO EPX	5.53e-07	6	70	3	CID000151120
Drug	3-(3,4-dimethoxyphenyl) acrylate	MPO LPO EPX	9.66e-07	7	70	3	CID000016848
Drug	N-(carboxyheptyl)maleimide	MPO LPO EPX	9.66e-07	7	70	3	CID000092656
Drug	benzidinediimine	MPO LPO EPX	9.66e-07	7	70	3	CID000115267
Drug	asarol methyl ether	MPO LPO EPX	9.66e-07	7	70	3	CID000097686
Drug	AC1L3RVN	MPO LPO EPX	1.54e-06	8	70	3	CID000094274
Drug	AC1O5E2B	MPO LPO EPX	2.31e-06	9	70	3	CID002724224
Drug	isothiocyanato thiocyanate	MPO LPO EPX	2.31e-06	9	70	3	CID000521282
Drug	deuterohemin	MPO LPO EPX	2.31e-06	9	70	3	CID003082177
Drug	trityrosine	MPO LPO EPX	3.29e-06	10	70	3	CID000164782
Drug	3-dimethylaminobenzoic acid	MPO LPO EPX	3.29e-06	10	70	3	CID000066837
Drug	naphthol AS-MX	MPO LPO EPX	3.29e-06	10	70	3	CID000066717
Drug	1,4-dimethoxybenzene	MPO LPO EPX	3.29e-06	10	70	3	CID000009016
Drug	ovothiol	MPO LPO EPX	3.29e-06	10	70	3	CID000129029
Drug	AC1NUTGS	MPO LPO EPX	4.51e-06	11	70	3	CID005460627
Drug	AC1Q5QKQ	MPO LPO EPX	6.00e-06	12	70	3	CID000134162
Drug	anisyl alcohol	MPO LPO EPX	6.00e-06	12	70	3	CID000007738
Drug	thiocyanate	MPO STON1 LPO GRIA1 EPX	6.44e-06	85	70	5	CID000000781
Drug	AC1L38JC	MPO LPO EPX	7.79e-06	13	70	3	CID000084962
Drug	2-bromohexadecanal	MPO EPX	9.32e-06	2	70	2	CID015701742
Drug	bromine trichloride	MPO EPX	9.32e-06	2	70	2	CID003014687
Drug	AC1L22VU	MPO EPX	9.32e-06	2	70	2	CID000040008
Drug	MLD987	MPO EPX	9.32e-06	2	70	2	CID006918516
Drug	3-methyl-2-benzothiazolinone hydrazone	MPO LPO EPX	9.89e-06	14	70	3	CID000014319
Drug	veratraldehyde	MPO LPO EPX	9.89e-06	14	70	3	CID000008419
Drug	2-amino-2-methyl-1-propanol	CELSR2 TMEM45B SULT1C2 CYP2F1 LAMA3 IRF6 CYP4F2 DNAH1	1.09e-05	346	70	8	ctd:C006551
Drug	reduced ascorbic acid	MPO LPO EPX LCT	1.21e-05	46	70	4	CID000000608
Drug	diacetyldeuteroheme	MPO LPO EPX	1.23e-05	15	70	3	CID004629150
Drug	aminostimil	MPO LPO EPX	1.23e-05	15	70	3	CID000021450
Drug	carbonate radical	MPO LPO EPX	1.23e-05	15	70	3	CID005460603
Drug	phenolate	MPO SULT1C2 LPO EPX SULT1C4 MAPK9 TRIB1	1.30e-05	254	70	7	CID000000996
Drug	monochlorodimedone	MPO LPO EPX	1.51e-05	16	70	3	CID000122278
Drug	AC1L8YWB	MPO LPO EPX	1.51e-05	16	70	3	CID000435142
Drug	AC1L97VK	MPO LPO EPX	1.51e-05	16	70	3	CID000439703
Drug	isobutyraldehyde	MPO LPO EPX	1.83e-05	17	70	3	CID000006561
Drug	4,4'-biphenol	MPO LPO EPX	1.83e-05	17	70	3	CID000007112
Drug	DBNBS	MPO LPO EPX	2.20e-05	18	70	3	CID000115207
Drug	AC1MON7Y	MPO LPO EPX	2.20e-05	18	70	3	CID003371803
Drug	triiodide	MPO LPO EPX	2.20e-05	18	70	3	CID000105054
Drug	naphthol AS	MPO LPO EPX	2.60e-05	19	70	3	CID000066719
Drug	HOBr	MPO LPO EPX	2.60e-05	19	70	3	CID000083547
Drug	3-nitrophenylacetic acid	MPO LPO EPX LCT	2.67e-05	56	70	4	CID000015876
Drug	4-chloro-1,2-benzoquinone	MPO EPX	2.79e-05	3	70	2	CID000093145
Drug	AC1L2HYK	MPO EPX	2.79e-05	3	70	2	CID000021263
Drug	1,2,4-trimethoxybenzene	MPO LPO	2.79e-05	3	70	2	CID000067284
Drug	indole-3-aldehyde	MPO LPO EPX	3.06e-05	20	70	3	CID000010256
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	CELSR2 KDM5C RBMX2 HIPK2 IRF5 GARRE1	3.31e-05	198	70	6	1244_DN
Drug	ethyl hydroperoxide	MPO LPO EPX	3.56e-05	21	70	3	CID000062472
Drug	AC1L1U8N	MPO LPO EPX	3.56e-05	21	70	3	CID000009983
Drug	Bouin's solution	MPO LPO EPX SEC14L2	3.99e-05	62	70	4	CID000124013
Drug	HOBt	MPO LPO EPX	4.11e-05	22	70	3	CID000075771
Drug	tryptophan	MPO LPO EPX	4.11e-05	22	70	3	CID005460840
Drug	p-phenetidine	MPO LPO EPX	4.11e-05	22	70	3	CID000009076
Drug	osmium tetroxide	MPO LPO EPX MAPK9	4.53e-05	64	70	4	CID000030318
Drug	m-phenylenediamine	MPO LPO EPX	4.72e-05	23	70	3	CID000007935
Drug	o-tolidine	MPO LPO EPX	4.72e-05	23	70	3	CID000008413
Drug	4-chloro-1-naphthol	MPO LPO EPX	4.72e-05	23	70	3	CID000011787
Drug	3,3',5,5'-tetramethylbenzidine	MPO LPO EPX	5.38e-05	24	70	3	CID000041206
Drug	p-nitrobenzyl chloride	MPO LPO EPX	5.38e-05	24	70	3	CID000007482
Drug	4-methylumbelliferone	SULT1C2 SULT6B1 KDM5D SULT1C4 LCT	5.43e-05	132	70	5	CID003364573
Drug	sodium borohydride	MPO LPO	5.57e-05	4	70	2	ctd:C025364
Drug	AC1L2O1K	MPO EPX	5.57e-05	4	70	2	CID000125126
Drug	i0830	MPO EPX	5.57e-05	4	70	2	CID000151254
Drug	2,6-dimethoxyphenol	MPO LPO EPX LCT	5.75e-05	68	70	4	CID000007041
Drug	hypothiocyanite	MPO LPO EPX	6.10e-05	25	70	3	CID000124984
Drug	atofluding	MPO LPO EPX	6.10e-05	25	70	3	CID000126342
Drug	thioanisole	MPO LPO EPX	6.10e-05	25	70	3	CID000007520
Drug	diiodotyrosine	MPO LPO EPX	6.10e-05	25	70	3	CID000006181
Drug	2-methyl-2-nitrosopropane	MPO LPO EPX	6.10e-05	25	70	3	CID000023272
Drug	A-E-C	MPO LPO IRF6 EPX	6.45e-05	70	70	4	CID006438040
Drug	naphthol AS-D chloroacetate	MPO LPO EPX KIT	6.81e-05	71	70	4	CID000160247
Drug	20-hydroxyleukotriene B4	MPO CYP4F2 EPX	6.88e-05	26	70	3	CID000001589
Drug	peracetic acid	MPO LPO EPX	6.88e-05	26	70	3	CID000006585
Drug	BHAC	MPO LPO EPX	7.72e-05	27	70	3	CID000003228
Drug	o-phenylenediamine	MPO LPO EPX	7.72e-05	27	70	3	CID000007243
Drug	o-anisidine	MPO LPO EPX	7.72e-05	27	70	3	CID000007000
Drug	dichloralurea	MPO LPO EPX	7.72e-05	27	70	3	CID000008313
Drug	2,7-diaminofluorene	MPO LPO EPX	7.72e-05	27	70	3	CID000010679
Drug	guaiacol	MPO SULT1C2 LPO EPX	8.45e-05	75	70	4	CID000000460
Drug	hypoiodite	MPO LPO EPX	8.63e-05	28	70	3	CID000123340
Drug	m-chloroperbenzoic acid	MPO LPO EPX	8.63e-05	28	70	3	CID000070297
Drug	tauroursocholate	MPO STON1 ATP8B1 MERTK LCT	8.76e-05	146	70	5	CID000005246
Drug	AC1L8TZY	MPO LPO EPX KIT	8.89e-05	76	70	4	CID000408095
Drug	CI-949	MPO EPX	9.26e-05	5	70	2	CID000159562
Drug	Hmpo	MPO LPO	9.26e-05	5	70	2	CID003081150
Disease	serum alanine aminotransferase measurement	FCSK SHROOM3 ITCH STON1 ZBTB7C CELSR2 PKD1L1 TMEM147 ADAMTS18 CYP4F2 ADGRA1 ATP8B1 MERTK TRIB1	1.14e-08	869	69	14	EFO_0004735
Disease	gallstones	UBR1 SHROOM3 TMEM147 ATP8B1 TRIB1	5.58e-06	108	69	5	EFO_0004210
Disease	hydrocephalus (implicated_via_orthology)	CELSR2 POMK HYDIN	1.15e-05	19	69	3	DOID:10908 (implicated_via_orthology)
Disease	syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)	KDM5C KDM5D	3.22e-05	4	69	2	DOID:0060809 (implicated_via_orthology)
Disease	Prader-Willi syndrome (implicated_via_orthology)	MAGEL2 NDN	3.22e-05	4	69	2	DOID:11983 (implicated_via_orthology)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	CELSR2 SULT1C2 TMEM147 SULT1C4 TRIB1 DNAH1	4.46e-05	274	69	6	EFO_0004530, EFO_0004612
Disease	cholelithiasis	SHROOM3 TMEM147 ATP8B1 TRIB1	5.51e-05	88	69	4	EFO_0004799
Disease	lactoperoxidase measurement	LPO EPX	8.03e-05	6	69	2	EFO_0020525
Disease	Congenital muscular dystrophy (disorder)	ITGA7 POMK	8.03e-05	6	69	2	C0699743
Disease	C-reactive protein measurement	PXDN ZBTB7C CELSR2 UBE4B PKD1 GRIA1 IRF5 MERTK ST8SIA3 KIT TRIB1	1.05e-04	1206	69	11	EFO_0004458
Disease	hepatitis C virus infection, cirrhosis of liver	PKD1L1 MERTK	1.12e-04	7	69	2	EFO_0001422, EFO_0003047
Disease	Gastrointestinal Stromal Sarcoma	PTCH2 HIPK2 KIT	1.84e-04	47	69	3	C3179349
Disease	Gastrointestinal Stromal Tumors	PTCH2 HIPK2 KIT	2.22e-04	50	69	3	C0238198
Disease	Squamous cell carcinoma of the head and neck	CCNA1 MERTK MAPK9	2.49e-04	52	69	3	C1168401
Disease	Royer Syndrome	MAGEL2 NDN	3.50e-04	12	69	2	C0265222
Disease	visceral heterotaxy (is_implicated_in)	PKD1L1 CFC1B	3.50e-04	12	69	2	DOID:0050545 (is_implicated_in)
Disease	Prader-Willi Syndrome	MAGEL2 NDN	4.13e-04	13	69	2	C0032897
Disease	lobe size	SULT1C2 SULT1C4	4.82e-04	14	69	2	EFO_0007666
Disease	gut microbiome measurement, taxonomic microbiome measurement	NRDE2 SHROOM3 SIPA1L3	5.04e-04	66	69	3	EFO_0007874, EFO_0007883
Disease	Situs ambiguus	SHROOM3 PKD1L1	5.55e-04	15	69	2	C0266642
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5C KDM5D	6.33e-04	16	69	2	DOID:0050888 (implicated_via_orthology)
Disease	total blood protein measurement	STON1 PKD1 ST6GAL1 TRIB1 HYDIN DNAH1	6.41e-04	449	69	6	EFO_0004536
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	CELSR2 TRIB1	8.05e-04	18	69	2	EFO_0008317, EFO_0008589
Disease	sodium-coupled monocarboxylate transporter 1 measurement	CELSR2 TRIB1	8.98e-04	19	69	2	EFO_0802076
Disease	cardiovascular system disease (is_implicated_in)	MPO UBR1	1.10e-03	21	69	2	DOID:1287 (is_implicated_in)
Disease	alcohol use disorder (implicated_via_orthology)	KDM5C EPS8L1 KDM5D UTY	1.14e-03	195	69	4	DOID:1574 (implicated_via_orthology)
Disease	myeloperoxidase (MPO)-DNA complex measurement	MPO EPX	1.21e-03	22	69	2	EFO_0011039
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	SHROOM3 CELSR2 TRIB1 DNAH1	1.26e-03	200	69	4	EFO_0004611, EFO_0020945
Disease	serum gamma-glutamyl transferase measurement	UBR1 ZBTB7C CELSR2 SIPA1L3 PKD1 TMEM147 ATP8B1 TRIB1	1.29e-03	914	69	8	EFO_0004532
Disease	myocardial infarction	SHROOM3 STON1 CELSR2 MERTK TRIB1	1.38e-03	350	69	5	EFO_0000612
Disease	lobe attachment	SULT6B1 ADAMTS18 CRYBG1 SULT1C4	1.42e-03	207	69	4	EFO_0007667
Disease	interstitial lung disease (is_marker_for)	MPO KIT	1.56e-03	25	69	2	DOID:3082 (is_marker_for)
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	SHROOM3 CELSR2 TRIB1 DNAH1	1.90e-03	224	69	4	EFO_0004530, EFO_0008317
Disease	ceramide measurement	ZBTB7C CELSR2 ATP8B1 SEC14L2	2.26e-03	235	69	4	EFO_0010222
Disease	triglyceride measurement, intermediate density lipoprotein measurement	SHROOM3 CELSR2 TRIB1	2.27e-03	111	69	3	EFO_0004530, EFO_0008595
Disease	coronary artery disease, factor VII measurement	ITCH CELSR2 TRIB1	2.27e-03	111	69	3	EFO_0001645, EFO_0004619

Protein segments in the cluster

Peptide	Gene	Start	Entry
AWEPSLGAFYGPAAI	ADGRA1	171	Q86SQ6
EEPLPYSWAFGEGAS	CFC1B	71	P0CG36
DPEGYGNPDFCWLSI	CELSR2	2501	Q9HCU4
GEDDTPSYRGFLIFW	ATP8B1	376	O43520
IDWPGEFPFAGTTFE	ADAMTS18	806	Q8TE60
AWIFLGGLPYELTEG	RBMX2	36	Q9Y388
SPWGELYDIFPSLLD	CYP2F1	211	P24903
YPGIKFEELFPDWIF	MAPK9	266	P45984
IAELFLGWPLYPGAS	HIPK2	391	Q9H2X6
EPAEYEFLWGPRAFL	MAGEL2	1176	Q9UJ55
FGFDPLAFPEFSWRG	LAMA3	746	Q16787
AGFPEPTIDWYFCPG	KIT	431	P10721
LISWVPGFDGYSPFR	MERTK	301	Q12866
VFEPSWAEFQDPLGY	KDM5D	16	Q9BY66
DNPEEPGEAWSYFGR	BEND2	651	Q8NDZ0
LPAEYEDGLSLPFGW	EPX	171	P11678
AEYEDGLSLPFGWTP	LPO	166	P22079
AEYEDGFSLPYGWTP	MPO	201	P05164
VEFFEPFWDSGEPRA	NRDE2	516	Q9H7Z3
GYWSAFIPDTPELGS	HEATR6	441	Q6AI08
WLLFEYPESSGPARG	KCNA3	221	P22001
EFLYGRFPEGFIWSA	LCT	1371	P09848
PGGVLFFWEHVAEPY	METTL7B	166	Q6UX53
PPFEIFFCFGEEWPD	IRF5	391	Q13568
FGEWCEFSPYEVGFP	PLA2G4B	451	P0C869
RLWVIFPGEEGLDYG	ITCH	576	Q96J02
DFSGGWSDTPPLAYE	FCSK	716	Q8N0W3
DGIPAVFWISGFFFP	DNAH1	4106	Q9P2D7
TLFFPLPDGTGWLYA	HYDIN	4706	Q4G0P3
WLLFEYPESSGPARG	KCNA6	161	P17658
TWPFPEFFTEGDGLH	GARRE1	886	O15063
EYLSWEGPGLPDFVF	CCNA1	21	P78396
FAAEFFGPFDPWRPS	CATIP	346	Q7Z7H3
DKFFYSFLEPWLGDG	CYP4F2	121	P78329
DGWPDLIVGAPYFFE	ITGA7	376	Q13683
LEPGEYPDLSFWDTE	CRYBG1	1181	Q9Y4K1
EEGPPYRPEFFSGWE	EPS8L1	411	Q8TE68
YRPEFFSGWEPPVTD	EPS8L1	416	Q8TE68
PGVFSFLDPLAYEIW	GRIA1	526	P42261
YDLDGCPVWYDIIGP	SEC14L2	91	O76054
LEFEWYFGEDPPVRT	PKD1L1	536	Q8TDX9
LPSPGGVLYTWDFGD	PKD1	1151	P98161
QPPFEIYLCFGEEWP	IRF6	366	O14896
IGPGDCEWFVVPEDY	UTY	1106	O14607
VPDIPSYGSWDEFFR	SULT6B1	156	Q6IMI4
PGDPLIETFWAFYQA	SAMD9L	556	Q8IVG5
PSGSPFLFWEQYLGL	PTCH2	946	Q9Y6C5
GWGFVSDFEELPPGL	PRSS57	161	Q6UWY2
FEDGTPRRGWPETYD	SIPA1L3	1041	O60292
DLLPGLAWSSEDFPY	SMIM28	101	A0A1B0GU29
DWPFQPYLVFDVGDG	SETX	2291	Q7Z333
FWPFGFDPNTREDLP	ST8SIA3	321	O43173
IYLEAFLEGGAPWGF	SHROOM3	26	Q8TF72
TDFPFNTSEWEGYLP	ST6GAL1	156	P15907
GDFVAPEQLWPYGED	POMK	251	Q9H5K3
DFPFPFAWLTGYLAI	SLC34A2	406	O95436
IGFVLFPPFGTPEWD	TMEM45B	191	Q96B21
WFFPSGREDLDIFPE	URGCP	316	Q8TCY9
PWFESVLEPGYIDSE	TRIB1	336	Q96RU8
ELGSDQEIPSDWYPF	STON1	656	Q9Y6Q2
PDPGTWEEYFETFIN	SULT1C2	151	O00338
DWLTELYGDQPPFSE	UBE4B	736	O95155
REFFLPSESWEFPGF	TEX52	41	A6NCN8
LPAPGTWEEYFETFL	SULT1C4	156	O75897
GDRLWYENPGVFSPA	PXDN	1246	Q92626
FTPLEWYLFGEDPDI	UBR1	71	Q8IWV7
FAPDFFPHLWPGDFG	ZBTB7C	251	A1YPR0
YPDPDFLWIEEPGGV	VSIG10	251	Q8N0Z9
PLLRGWFFEEFVPGV	TIGD5	326	Q53EQ6
FFPTWEGGIYDFIGE	TMEM147	56	Q9BVK8
YFWGIPFCPDGVDPN	UIMC1	276	Q96RL1
VFEPSWAEFRDPLGY	KDM5C	16	P41229
RYFWAVPEGEFSCEP	LRFN4	266	Q6PJG9
PYVEPPEYEFFWGSR	NDN	251	Q99608